|
Relationship between corneal exam findings, best-corrected visual acuity (BCVA), and ocular symptoms in patients with relapsed or refractory multiple myeloma (RRMM) receiving belantamab mafodotin (belamaf). |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Sanofi; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Sanofi; Takeda |
Research Funding - Amgen (Inst); Genesis Pharmaceuticals (Inst); Janssen-Cilag (Inst); Sanofi (Inst); Takeda (Inst) |
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Cilag; Takeda |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Celgene; GlaxoSmithKline; Janssen; Takeda |
Consulting or Advisory Role - Abbvie; Celgene; GlaxoSmithKline; Takeda |
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Takeda |
|
|
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Sanofi; Takeda |
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Sanofi; Takeda |
|
|
Consulting or Advisory Role - GlaxoSmithKline |
|
|
Stock and Other Ownership Interests - EyeGate Pharma |
Honoraria - GlaxoSmithKline |
Consulting or Advisory Role - GlaxoSmithKline |
Research Funding - GlaxoSmithKline |
|
|
Honoraria - Novartis Pharmaceuticals UK Ltd. |
Consulting or Advisory Role - GlaxoSmithKline |
Travel, Accommodations, Expenses - Bayer UK; GenSight Biologics |
|
|
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
|
|
Employment - GlaxoSmithKline |
Stock and Other Ownership Interests - GlaxoSmithKline |
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline |
|
|
|
Stock and Other Ownership Interests - Takeda |
|
Consulting or Advisory Role - Takeda |
Research Funding - Takeda (Inst) |
Travel, Accommodations, Expenses - Takeda |
|
|
No Relationships to Disclose |